Termination

MIDOSTAURIN 25MG CAPSULES, 56 capsules

  • Belfast Health & Social Care Trust

UK12: Procurement termination notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-036334

Procurement identifier (OCID): ocds-h6vhtk-054fc5 (view related notices)

Published 1 July 2025, 11:12am



Contract 1. MIDOSTAURIN 25MG CAPSULES, 56 capsules, pack

This contract will not be signed.

Date of decision not to sign contract

1 July 2025

Supplier

Contract value

  • £300,000 excluding VAT
  • £300,000 including VAT

Contract dates

  • 1 July 2025 to 30 June 2027
  • 2 years

Supplier

NOVARTIS PHARMACEUTICALS UK LIMITED

  • Companies House: 00119006
  • Public Procurement Organisation Number: PJTX-5182-QVLR

2nd Floor, The Westworks Building White City Place

London

W12 7FQ

United Kingdom

Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. MIDOSTAURIN 25MG CAPSULES, 56 capsules, pack


Contracting authority

Belfast Health & Social Care Trust

  • Public Procurement Organisation Number: PLQJ-5727-JCLR

Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital

Belfast

BT12 6BA

United Kingdom

Region: UKN06 - Belfast

Organisation type: Public authority - central government

Devolved regulations that apply: Northern Ireland